HEMImprove 1.0 in Children and Adolescents With Unilateral Cerebral Palsy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorUniversity of Castilla-La Mancha

About this trial

This study aims to evaluate the effectiveness and usability of HEMImprove 1.0, a gamified mobile application designed to improve upper limb motor function in adolescents with unilateral cerebral palsy. Participants will be randomly assigned to an intervention group using the app or a control group performing conventional home exercises. The intervention will last four weeks, with assessments before and after the intervention to measure motor function, motivation, and quality of life improvements.

Eligibility criteria

Qualifiers

Adolescents aged 12 to 18 years diagnosed with unilateral cerebral palsy.

Ability to use the mobile app independently or with minimal assistance.

Informed consent provided.

Disqualifiers

Severe cognitive impairment.

Recent upper limb surgery (within 6 months).

Recent botulinum toxin treatment (within 3 months).

Other neurological or orthopedic disorders affecting upper limb function.

Trial design

Treatments tested in this trial

  • HEMImprove APP
  • exercises to upper limb

Treatment groups

36 Participants
are divided into 2 treatment groups

Locations

This trial has no locations